ALIVUS
Invest with MTF
Invest Now
Invest in Alivus Life Sciences with 3.07X leverage
Performance
- Low
- ₹904
- High
- ₹932
- 52 Week Low
- ₹850
- 52 Week High
- ₹1,251
- Open Price₹925
- Previous Close₹891
- Volume158,323
Investment Returns
- Over 1 Month -1.96%
- Over 3 Month -3.76%
- Over 6 Month -17.64%
- Over 1 Year -16.67%
Smart Investing Starts Here Start SIP with Alivus Life Sciences for Steady Growth!
Alivus Life Sciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 21.2
- PEG Ratio
- 0.8
- Market Cap Cr
- 11,226
- P/B Ratio
- 4
- Average True Range
- 23.82
- EPS
- 43.23
- Dividend Yield
- 0.5
- MACD Signal
- -9.87
- RSI
- 47.16
- MFI
- 16.72
Alivus Life Sciences Financials
Alivus Life Sciences Technicals
EMA & SMA
Current Price
₹915.05
+
24.55
(2.76%)
- Bearish Moving Average 11
- Bullish Moving Average 5
- 20 Day
- ₹917.79
- 50 Day
- ₹937.22
- 100 Day
- ₹964.10
- 200 Day
- ₹985.49
Resistance and Support
916.98
- R3 958.17
- R2 945.08
- R1 930.07
- S1 901.97
- S2 888.88
- S3 873.87
Alivus Life Sciences Corporate Actions - Bonus, Splits, Dividends
Alivus Life Sciences F&O
About Alivus Life Sciences
- NSE Symbol
- ALIVUS
- BSE Symbol
- 543322
- Managing Director & CEO
- Dr. Yasir Rawjee
- ISIN
- INE03Q201024
Similar Stocks to Alivus Life Sciences
Alivus Life Sciences FAQs
Alivus Life Sciences share price is ₹915 As on 08 November, 2025 | 06:35
The Market Cap of Alivus Life Sciences is ₹11226 Cr As on 08 November, 2025 | 06:35
The P/E ratio of Alivus Life Sciences is 21.2 As on 08 November, 2025 | 06:35
The PB ratio of Alivus Life Sciences is 4 As on 08 November, 2025 | 06:35
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.